Total Payments
$55,626
2023 Payments
$60.67
Companies
22
Transactions
319
Medicare Patients
2,687
Medicare Billing
$866,882
Payment Breakdown by Category
Other$48,620 (87.4%)
Food & Beverage$5,302 (9.5%)
Travel$1,683 (3.0%)
Consulting$17.75 (0.0%)
Education$3.85 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $38,990 | 23 | 70.1% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $9,600 | 4 | 17.3% |
| Food and Beverage | $5,302 | 274 | 9.5% |
| Travel and Lodging | $1,683 | 14 | 3.0% |
| Debt forgiveness | $29.57 | 2 | 0.1% |
| Consulting Fee | $17.75 | 1 | 0.0% |
| Education | $3.85 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $39,332 | 143 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $8,351 | 26 | $0 (2023) |
| Allergan Inc. | $3,548 | 13 | $0 (2019) |
| Valeant Pharmaceuticals North America LLC | $2,158 | 5 | $0 (2017) |
| Takeda Pharmaceuticals U.S.A., Inc. | $601.66 | 36 | $0 (2023) |
| Janssen Biotech, Inc. | $328.61 | 29 | $0 (2023) |
| QOL Medical, LLC | $312.58 | 17 | $0 (2022) |
| Celgene Corporation | $279.85 | 6 | $0 (2022) |
| Intercept Pharmaceuticals, Inc. | $164.90 | 9 | $0 (2021) |
| Synergy Pharmaceuticals Inc | $129.49 | 8 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $60.67 | 4 | Janssen Biotech, Inc. ($30.39) |
| 2022 | $4,907 | 61 | ABBVIE INC. ($4,358) |
| 2021 | $7,388 | 57 | AbbVie Inc. ($6,815) |
| 2020 | $11,980 | 34 | AbbVie Inc. ($11,800) |
| 2019 | $9,384 | 51 | AbbVie, Inc. ($6,973) |
| 2018 | $6,557 | 44 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($6,078) |
| 2017 | $15,349 | 68 | AbbVie, Inc. ($9,331) |
All Payment Transactions
319 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/16/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Gastroenterology | ||||||
| 01/14/2023 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: Immunology | ||||||
| 01/12/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: INTERNAL MEDICINE | ||||||
| 01/03/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: Immunology | ||||||
| 12/21/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Gastroenterology | ||||||
| 12/14/2022 | Amgen Inc. | AVSOLA (Biological) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: Inflammation | ||||||
| 12/12/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $25.11 | General |
| 12/08/2022 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $6.07 | General |
| Category: Immunology | ||||||
| 12/06/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2022 | Organon LLC | RENFLEXIS (Drug) | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: INFLIXIMAB | ||||||
| 11/05/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: IMMUNOLOGY | ||||||
| 10/18/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $10.58 | General |
| Category: IMMUNOLOGY | ||||||
| 10/18/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $5.13 | General |
| Category: IMMUNOLOGY | ||||||
| 10/14/2022 | ABBVIE INC. | LINZESS (Drug), VIBERZI, CREON | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/13/2022 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Immunology | ||||||
| 10/13/2022 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Immunology | ||||||
| 10/10/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: IMMUNOLOGY | ||||||
| 10/05/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: Immunology | ||||||
| 10/04/2022 | ABBVIE INC. | CREON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,875.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/04/2022 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $5.10 | General |
| Category: Immunology | ||||||
| 10/03/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $28.77 | General |
| 09/29/2022 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $124.95 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/27/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $11.58 | General |
| Category: IMMUNOLOGY | ||||||
| 09/20/2022 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: Immunology | ||||||
| 09/14/2022 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $12.22 | General |
| Category: INTERNAL MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 20 | 835 | 13,282 | $1.1M | $310,621 |
| 2021 | 20 | 963 | 9,669 | $1.1M | $266,761 |
| 2020 | 22 | 889 | 10,845 | $1.1M | $289,500 |
Total Patients
2,687
Total Services
33,796
Medicare Billing
$866,882
Procedure Codes
62
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3380 | Injection, vedolizumab, 1 mg | Office | 2022 | 31 | 11,100 | $421,800 | $193,120 | 45.8% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2022 | 20 | 1,330 | $186,200 | $38,254 | 20.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 127 | 127 | $136,335 | $14,200 | 10.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 76 | 76 | $93,176 | $13,040 | 14.0% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 50 | 50 | $45,141 | $8,034 | 17.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 68 | 82 | $23,206 | $6,857 | 29.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 83 | 85 | $80,325 | $6,494 | 8.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 53 | 90 | $15,768 | $4,767 | 30.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 43 | 43 | $16,770 | $4,679 | 27.9% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 66 | 66 | $48,440 | $4,584 | 9.5% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 21 | 21 | $19,131 | $3,215 | 16.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 30 | 30 | $9,884 | $2,998 | 30.3% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 21 | 22 | $7,326 | $2,197 | 30.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 14 | 14 | $6,852 | $2,065 | 30.1% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 17 | 17 | $14,689 | $1,992 | 13.6% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 33 | 39 | $8,931 | $1,929 | 21.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 22 | 22 | $4,356 | $1,317 | 30.2% |
| 43450 | Dilation of esophagus | Facility | 2022 | 17 | 17 | $8,551 | $486.57 | 5.7% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2022 | 12 | 13 | $1,846 | $280.03 | 15.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 31 | 38 | $494.00 | $112.65 | 22.8% |
| J3380 | Injection, vedolizumab, 1 mg | Office | 2021 | 22 | 7,200 | $273,600 | $119,785 | 43.8% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2021 | 17 | 1,450 | $203,000 | $48,361 | 23.8% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 115 | 119 | $142,522 | $22,155 | 15.5% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 130 | 131 | $140,432 | $12,032 | 8.6% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2021 | 63 | 64 | $57,152 | $10,435 | 18.3% |
About Dr. Joshua Evans, M.D
Dr. Joshua Evans, M.D is a Internal Medicine healthcare provider based in Omaha, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1861579450.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joshua Evans, M.D has received a total of $55,626 in payments from pharmaceutical and medical device companies, with $60.67 received in 2023. These payments were reported across 319 transactions from 22 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($38,990).
As a Medicare-enrolled provider, Evans has provided services to 2,687 Medicare beneficiaries, totaling 33,796 services with total Medicare billing of $866,882. Data is available for 3 years (2020–2022), covering 62 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Gastroenterology
- Location Omaha, NE
- Active Since 11/01/2006
- Last Updated 07/07/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1861579450
Products in Payments
- XIFAXAN (Drug) $10,404
- Creon (Drug) $4,899
- CREON (Drug) $4,429
- LINZESS (Drug) $3,634
- Entyvio (Biological) $362.77
- ZEPOSIA (Drug) $279.85
- STELARA (Biological) $236.25
- ENTYVIO (Biological) $214.87
- Sucraid (Drug) $168.05
- SUCRAID (Drug) $144.53
- Trulance (Drug) $129.49
- HUMIRA (Biological) $129.17
- Humira (Biological) $108.63
- REMICADE (Biological) $92.36
- OCALIVA (Drug) $84.23
- OCA (Drug) $80.67
- RINVOQ (Biological) $75.11
- MOTEGRITY (Drug) $67.07
- TRULANCE (Drug) $57.26
- DUPIXENT (Biological) $46.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Omaha
Mojtaba Akhtari, M.d, M.D
Internal Medicine — Payments: $1.6M
Internal Medicine $1.6M
Dr. Matthew Lunning, D.o, D.O
Internal Medicine — Payments: $650,808
Internal Medicine $650,808
Michael Dunn, M.d, M.D
Internal Medicine — Payments: $221,491
Internal Medicine $221,491
Dr. Brian Boer, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $96,162
Internal Medicine $96,162
Dr. Trevor Van Schooneveld, M.d, M.D
Internal Medicine — Payments: $91,007
Internal Medicine $91,007
Dr. Michael Schafer, Md, MD
Internal Medicine — Payments: $60,335
Internal Medicine $60,335